Animal-testing pipeline disrupted
Ridglan Farms, one of America’s main suppliers of beagles for laboratory use, will end dog sales by mid-2026 under a court agreement following a felony animal-cruelty probe, Vox reported. The move echoes the 2022 closure of Envigo after a similar investigation. Together, the exits will reshape how research labs source animals for testing, forcing institutions to seek non-animal methods.

Shift toward humane science
Ridglan will retain limited on-site research while phasing out sales. Universities and pharma firms are expanding organoid, in-vitro, and computational toxicology alternatives. Regulators face pressure to fund and validate these models faster. The shift marks a cultural inflection: public tolerance for canine testing is eroding, and scientific rigor must now coexist with ethical innovation.